KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma: Mantle-cell lymphoma is a B-cell non-Hodgkin’s lymphoma that generally has an aggressive clinical course. Bruton’s tyrosine kinase (BTK) inhibitors have greatly improved outcomes in patients with relapsed or refractory mantle-cell lymphoma, yet patients who have disease progression after the…